US Patent Issued to Ankh Life Sciences on Sept. 23 for "Low-temperature synthesis of thymoquinone and harmaline compounds" (Kansas Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,872, issued on Sept. 23, was assigned to Ankh Life Sciences Ltd. (Dublin).

"Low-temperature synthesis of thymoquinone and harmaline compounds" was invented by Gene H. Zaid (Hutchinson, Kan.), Beth Ann Wolf (Hutchinson, Kan.), Rachel Elizabeth Ropp (Hutchinson, Kan.), Krishna Mohan Donavalli (Sterling, Kan.) and Rajni Verma (Sterling, Kan.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Low-temperature syntheses of thymoquinone/harmaline compounds which are useful for the treatment of human diabetes and cancers, and the derivatives, solvates, prodrugs, isomers, and tautomers of such compounds."

The patent was filed on Feb. 11, 2022, under Applicatio...